Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 10148
TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516896(US11104670, Example 24)
Affinity DataIC50: 98nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516891(US11104670, Example 20)
Affinity DataIC50: 133nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516895(US11104670, Example 23)
Affinity DataIC50: 143nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516897(US11104670, Example 25)
Affinity DataIC50: 216nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516899(US11104670, Example 27)
Affinity DataIC50: 350nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516903(US11104670, Example 34)
Affinity DataIC50: 362nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516900(US11104670, Example 28)
Affinity DataIC50: 500nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516902(US11104670, Example 33)
Affinity DataIC50: 509nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516901(US11104670, Example 32)
Affinity DataIC50: 547nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516898(US11104670, Example 26)
Affinity DataIC50: 550nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516892(US11104670, Example 21)
Affinity DataIC50: 702nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516904(US11104670, Example 35)
Affinity DataIC50: 933nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM516894(US11104670, Example 22)
Affinity DataIC50: 1.11E+3nMAssay Description:At the assay day cells were washed 3× with assay buffer (as described above), 10 μL buffer remained in the wells after washing. 10 μL Ca ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent